Which drug maker spent the most on lobbying this summer? The answer will surprise you
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Pandemic preparedness is already off Congress’ priority list
